Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis B

NCT03672188 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: VIR-2218
DRUG: Placebo

Sponsor

Vir Biotechnology, Inc.

Collaborators

[object Object]